Pharmalot… Pharmalittle… Morning Edition

Make a comment

By Ed Silverman // September 24th, 2008 // 7:35 am

coffeeandpaper4Welcome back. We apologize for the interruption late yesterday, but those speaking engagements can be fun. Now, though, we are once again glued to the laptop and poking around for interesting developments. Hope your day goes well…

Genzyme Expects Ruling On Myozyme (The Boston Globe)

Pfizer Sees Opportunity In Stem Cells (Yahoo/Reuters)

Teva Denied Motion On Pulmicort Patent (Bloomberg News)

Boehringer Clot Drug Endorsed By UK’s NICE (Yahoo/Reuters)

Jump to comments

Share

Leave a Comment

Subscribe

RSS Feed

Comments feed for this post only.

« Lung Med Linked To Heart Attack And Deaths
Genentech Warns Of Liver Damage From Tarceva »

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/